Cargando…
Matrix Metallopeptidase-Gene Signature Predicts Stage I Lung Adenocarcinoma Survival Outcomes
Tumor recurrence poses a significant challenge to the clinical management of stage I lung adenocarcinoma after curative surgical resection. Matrix metalloproteinases (MMPs) increase expression and correlate with recurrence and metastasis in surgically resected non-small cell lung cancer. However, th...
Autores principales: | Liu, Chia-Hsin, Di, Yuanpu Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917043/ https://www.ncbi.nlm.nih.gov/pubmed/36768704 http://dx.doi.org/10.3390/ijms24032382 |
Ejemplares similares
-
Profile of Expression of Genes Encoding Matrix Metallopeptidase 9 (MMP9), Matrix Metallopeptidase 28 (MMP28) and TIMP Metallopeptidase Inhibitor 1 (TIMP1) in Colorectal Cancer: Assessment of the Role in Diagnosis and Prognostication
por: Lorenc, Zbigniew, et al.
Publicado: (2017) -
p63 transcriptionally regulates the expression of matrix metallopeptidase 13
por: Celardo, Ivana, et al.
Publicado: (2014) -
Localised release of matrix metallopeptidase 8 in fatal cerebral malaria
por: Georgiadou, Athina, et al.
Publicado: (2021) -
Association between Matrix Metallopeptidase 9 Polymorphism and Breast Cancer Risk
por: Felizi, Rogério Tadeu, et al.
Publicado: (2018) -
Integrative Analysis Constructs an Extracellular Matrix-Associated Gene Signature for the Prediction of Survival and Tumor Immunity in Lung Adenocarcinoma
por: Xiao, Lingyan, et al.
Publicado: (2022)